BIO-key (R) International Exhibiting at the 2010 AABB Annual Meeting and Cellular Therapy and Transfusion Medicine Expo

/ Source: GlobeNewswire

WALL, N.J., Oct. 8, 2010 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a leader in finger-based biometric identification solutions for the healthcare industry, is showcasing donor and patient identity solutions at the 2010 AABB CTTXPO conference being held at the Baltimore Convention Center from October 9-12. With the recent announcement of The Institute for Transfusion MedicineSM (ITxMSM), the third-largest U.S. Independent Blood Center, as the most recent blood center deploying BIO-key's fingerprint search and identification solution, BIO-key continues its dominant position as the premier biometric ID provider for blood centers. At this event, BIO-key will provide hands-on product demonstrations of its identification technology in booth #948 and in its partner Healthcare-ID's booth #859.

BIO-key will be showcasing donor and patient search and identification solutions that can be quickly integrated into any new or existing process. BIO-key's mobile biometric identification platform provides blood centers with the ability to securely capture and transmit fingerprint biometric data from laptops, tablets and desktop computers to establish the identity of donors, a requirement of every remote blood drive. Additionally, with the emergence of smartphones that include embedded fingerprint readers, blood centers will have the ability to utilize these devices to collect fingerprint images for establishing the identity of donors.

The CTTXPO offers one of the most extensive and diverse education programs available to professionals in the transfusion medicine and related biological therapies industry. This is the most significant annual event for the blood banking, transfusion medicine and cellular and related biological therapy communities worldwide to learn of the latest advancements and explore state-of-the-art products and services. AABB member facilities in the US alone are responsible for collecting virtually all of the nation's blood supply and transfusing more than 80 percent of all blood and blood components used in the United States.

"Patient safety is critical to every step in the blood collection process. BIO-key biometric identity solutions provide superior accuracy, speed and convenience for healthcare organizations looking to establish the identity of blood donors, patients and staff at any point in the donor and patient care process," commented Mike DePasquale, CEO of BIO-key International. "BIO-key identity solutions are a cost effective alternative to traditional identification methods and deliver a tangible return for blood centers and healthcare organizations by reducing risk, improving user convenience, lowering operating costs and improving donor & patient safety."

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. ()

BIO-key Safe Harbor Statement

Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act").  The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements.  Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act.  These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.  These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel.  For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 and its other filings with the Securities and Exchange Commission.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

CONTACT: BIO-key International, Inc. Bud Yanak 732-359-1100